Clinical Trials Browser

Phase 1/2 × Active not recruiting × Malignant Solid Tumor × Clear all

NCT04632108 2025-09-11

A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasm

Malignant Solid Tumor